Feed AMTX
AM

Aemetis, Inc. AMTX · NASDAQ

$1.30 +8.33% (+$0.10)

Summary

31 / 100 · Bulios Score

What speaks for it

None of the indicators we track stands out on the positive side.

What to watch

  • The company made a loss over the last 12 months.
  • Revenue fell by 6.8% a year over the last 3 years.
  • It missed profit estimates 4 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 4.7% a year over 5 years. Over the last 3 years it fell by 6.8% a year.

Growth in detail

Does it make money?

Poorly

Over the last 12 months it made a loss of $60.2M.

Profitability in detail

Is it financially healthy?

Debt is a burden

Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $3.17 is 144% above today's price. 71% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

Ethanol Sales brings in 79% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy